The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Recent advances in the discovery and delivery of vaccine adjuvants
Open accessAbstract
Adjuvant design has historically had a touch of alchemy at its heart due to its reliance on the complex biology of innate immune activation. However, a new mechanistic understanding of innate immunity, combined with new adjuvant and delivery platforms for exploiting this knowledge, has led to significant advances recently. Although many challenges remain, the field is moving rapidly and the proper tools and methodologies are in place for the use of traditional drug discovery engines in guiding the development of vaccine adjuvants. In this review, we outline the current trends in immune potentiator, delivery system and adjuvant design that will shape the vaccines of the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., & Akira, S. (2002) · Nature Immunology · doi:10.1038/ni758 · Cited by 2,522
Nasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Collaborative Induction of Inflammatory Responses by Dectin-1 and Toll-like Receptor 2
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., & Underhill, D. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021787 · Cited by 1,643
Origin, maturation and antigen presenting function of dendritic cells
Cella, M., Sallusto, F., & Lanzavecchia, A. (1997) · Current Opinion in Immunology · doi:10.1016/s0952-7915(97)80153-7 · Cited by 1,320
Maintenance of Serological Memory by Polyclonal Activation of Human Memory B Cells
Bernasconi, N. L., Traggiai, E., & Lanzavecchia, A. (2002) · Science · doi:10.1126/science.1076071 · Cited by 1,304
Jenkins, M. K., & Schwartz, R. H. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.302 · Cited by 1,170
TREM-1 amplifies inflammation and is a crucial mediator of septic shock
Bouchon, A., Facchetti, F., Weigand, M. A., & Colonna, M. (2001) · Nature · doi:10.1038/35074114 · Cited by 1,090
CD91 Is a Common Receptor for Heat Shock Proteins gp96, hsp90, hsp70, and Calreticulin
Basu, S., Binder, R. J., Ramalingam, T., & Srivastava, P. K. (2001) · Immunity · doi:10.1016/s1074-7613(01)00111-x · Cited by 900
Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo
Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M., & Muller, W. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80149-1 · Cited by 900
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G., & Bauer, S. (2002) · Nature Immunology · doi:10.1038/ni0602-499 · Cited by 838
The Influence of Antigen Organization on B Cell Responsiveness
Bachmann, M. F., Rohrer, U. H., Kündig, T. M., Bürki, K., Hengartner, H., & Zinkernagel, R. M. (1993) · Science · doi:10.1126/science.8248784 · Cited by 717
Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA
Cella, M., Salio, M., Sakakibara, Y., Langen, H., Julkunen, I., & Lanzavecchia, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.821 · Cited by 709
(1992) · International Journal of Biochemistry · doi:10.1016/0020-711x(92)90281-5 · Cited by 671
Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547
Zinkernagel, R. M., Ehl, S., Aichele, P., Oehen, S., Kündig, T., & Hengartner, H. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb00969.x · Cited by 489
Cationic microparticles: A potent delivery system for DNA vaccines
Singh, M., Briones, M., Ott, G., & O'Hagan, D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.811 · Cited by 489
Self-citationVaccine design : the subunit and adjuvant approach
Powell, M. F., Newman, M. J., & Burdman, J. R. (1995) · Plenum Press eBooks · Cited by 451
Mikszta, J. A., Alarcon, J. B., Brittingham, J. M., Sutter, D. E., Pettis, R. J., & Harvey, N. G. (2002) · Nature Medicine · doi:10.1038/nm0402-415 · Cited by 398
Matriano, J. A., Cormier, M., Johnson, J., Young, W. A., Buttery, M., Nyam, K., & Daddona, P. E. (2002) · Pharmaceutical Research · doi:10.1023/a:1013607400040 · Cited by 373
Roy, M. J., Wu, M. S., Barr, L. J., Fuller, J. T., Tussey, L. G., Speller, S., Culp, J., Burkholder, J. K., Swain, W. F., Dixon, R. M., et al. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00302-9 · Cited by 360
An ancient system of host defense
Medzhitov, R., & Janeway, C. A. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80024-1 · Cited by 327
Transcutaneous immunization: A human vaccine delivery strategy using a patch
Glenn, G. M., Taylor, D. N., Li, X., Frankel, S., Montemarano, A., & Alving, C. R. (2000) · Nature Medicine · doi:10.1038/82225 · Cited by 321
(1998) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49891998000900018 · Cited by 294
CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells
Liu, N., Ohnishi, N., Ni, L., Akira, S., & Bacon, K. B. (2003) · Nature Immunology · doi:10.1038/ni941 · Cited by 293
A month–long effect from a single injection of microencapsulated human growth hormone
Johnson, O. L., Cleland, J. L., Lee, H. J., Charnis, M., Duenas, E., Jaworowicz, W., Shepard, D., Shahzamani, A., Jones, A. J. S., & Putney, S. D. (1996) · Nature Medicine · doi:10.1038/nm0796-795 · Cited by 292
Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
Rappuoli, R., Pizza, M., Douce, G., & Dougan, G. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01523-6 · Cited by 284
Skin immunization made possible by cholera toxin
Glenn, G. M., Rao, M., Matyas, G. R., & Alving, C. R. (1998) · Nature · doi:10.1038/36014 · Cited by 261
Giuliani, M. M., Del Giudice, G., Giannelli, V., Dougan, G., Douce, G., Rappuoli, R., & Pizza, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1123 · Cited by 258
Recent Advances in Vaccine Adjuvants
Singh, M., & O'Hagan, D. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016104910582 · Cited by 245
Self-citationRecent Advances in the Stabilization of Proteins Encapsulated in Injectable PLGA Delivery Systems
Schwendeman, S. P. (2002) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v19.i1.20 · Cited by 235
JEGERLEHNER, A. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00266-9 · Cited by 226
A Compendium of Vaccine Adjuvants and Excipients
Vogel, F. R., & Powell, M. F. (1995) · Pharmaceutical Biotechnology · doi:10.1007/978-1-4615-1823-5_7 · Cited by 217
Microparticles as vaccine adjuvants and delivery systems
O’Hagan, D. T., & Singh, M. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.269 · Cited by 214
Self-citationO'Hagan, D., Singh, M., Ugozzoli, M., Wild, C., Barnett, S., Chen, M., Schaefer, M., Doe, B., Otten, G. R., & Ulmer, J. B. (2001) · Journal of Virology · doi:10.1128/jvi.75.19.9037-9043.2001 · Cited by 178
Self-citationDenis-Mize, K. S., Dupuis, M., MacKichan, M. L., Singh, M., Doe, B., O'Hagan, D., Ulmer, J. B., Donnelly, J. J., McDonald, D. M., & Ott, G. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301347 · Cited by 167
Self-citationAdjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN
Vasilakos, J. P., Smith, R. M., Gibson, S. J., Lindh, J. M., Pederson, L. K., Reiter, M. J., Smith, M. H., & Tomai, M. A. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1689 · Cited by 155
Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis
Dupuis, M., Denis-Mize, K. S., LaBarbara, A., Peters, W., Charo, I. F., McDonald, D. M., & Ott, G. S. (2001) · European Journal of Immunology · Cited by 145
Microparticles and polymers for the mucosal delivery of vaccines
O’Hagan, D. T. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00045-3 · Cited by 143
Self-citationA novel bioadhesive intranasal delivery system for inactivated influenza vaccines
Singh, M., Briones, M., & O’Hagan, D. T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00330-8 · Cited by 135
Self-citationJackson, L. A., Austin, G., Chen, R. T., Stout, R. R., Destefano, F. R., Gorse, G. J., Newman, F. K., Yu, O., & Weniger, B. G. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00225-0 · Cited by 132
Kazzaz, J., Neidleman, J. A., Singh, M., Ott, G. S., & O’Hagan, D. T. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00226-1 · Cited by 127
Self-citationScharton‐Kersten, T., Yu, J., Vassell, R. A., O’Hagan, D. T., Alving, C. R., & Glenn, G. M. (2000) · Infection and Immunity · doi:10.1128/iai.68.9.5306-5313.2000 · Cited by 125
Self-citationVaccine adjuvants : preparation methods and research protocols
O’Hagan, D. T. (2000) · Humana Press eBooks · Cited by 124
Self-citationCationic Microparticles Are an Effective Delivery System for Immune Stimulatory CpG DNA
Singh, M., Ott, G. S., Kazzaz, J., Ugozzoli, M., Briones, M., Donnelly, J., & O’Hagan, D. T. (2001) · Pharmaceutical Research · doi:10.1023/a:1012269226066 · Cited by 115
Self-citationKatz, D. E., Delorimier, A., Wolf, M. K., Hall, E. R., Cassels, F. J., van Hamont, J. E., Newcomer, R., Davachi, M. A., Taylor, D. N., & McQueen, C. E. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00613-8 · Cited by 109
Cumulative Toll-Like Receptor Activation in Human Macrophages Treated with Whole Bacteria
Nau, G. J., Schlesinger, A., Richmond, J. F. L., & Young, R. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5203 · Cited by 101
Epstein, J. E., Gorak, E. J., Charoenvit, Y., Wang, R., Freydberg, N., Osinowo, O., Richie, T. L., Stoltz, E. L., Trespalacios, F. C., Nerges, J. A., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340260201644 · Cited by 100
An Outbreak of Hepatitis B Associated With Jet Injections in a Weight Reduction Clinic
Canter, J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390200105020 · Cited by 97
Edelman, R. (2003) · Expert Review of Vaccines · doi:10.1586/14760584.2.2.167 · Cited by 92
Royle, M. C. J., Tötemeyer, S. S., Alldridge, L. C., Maskell, D. J., & Bryant, C. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5445 · Cited by 86
Otten, G. R., Schaefer, M. E., Greer, C. E., Calderon-Cacia, M., Coit, D., Kazzaz, J., Medina-Selby, A., Selby, M., Singh, M., Ugozzoli, M., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.6087-6092.2003 · Cited by 61
Self-citationGiannelli, V., Fontana, M. R., Giuliani, M. M., Guangcai, D., Rappuoli, R., & Pizza, M. (1997) · Infection and Immunity · doi:10.1128/iai.65.1.331-334.1997 · Cited by 52
Barackman, J. D., Ott, G. S., Pine, S. O., & O’Hagan, D. T. (2001) · Clinical and Diagnostic Laboratory Immunology · doi:10.1128/cdli.8.3.652-657.2001 · Cited by 39
Self-citation
Cited by
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Vaccine adjuvants: mechanisms and platforms
Zhao, T., Cai, Y., Jiang, Y., He, X., Wei, Y., Yu, Y., & Tian, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01557-7 · Cited by 1,020
Targeting the innate immune response with improved vaccine adjuvants
Pashine, A., Valiante, N. M., & Ulmer, J. B. (2005) · Nature Medicine · doi:10.1038/nm1210 · Cited by 555
Self-citationTargeting dendritic cells with biomaterials: developing the next generation of vaccines
Reddy, S. T., Swartz, M. A., & Hubbell, J. A. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.005 · Cited by 406
Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy
Demento, S. L., Eisenbarth, S. C., Foellmer, H. G., Platt, C., Caplan, M. J., Mark Saltzman, W., Mellman, I., Ledizet, M., Fikrig, E., Flavell, R. A., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.034 · Cited by 290
Metadata
- Authors
- O'Hagan, D. T., & Valiante, N. M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2003-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 727-735
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1968114019
- Cited by
- 434
- References
- 57
- FWCI
- 1.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.